G1 Therapeutics, Inc. short interest in 2024
In 2024, G1 Therapeutics, Inc.'s disclosed short interest ran from 6.28% of shares outstanding on 12 Jan 2024 to 8.29% on 13 Sep 2024, a change of +2.01 percentage points. The year's high was 13.46% on 15 Jul 2024 and its low 4.67% on 15 Apr 2024, averaging 7.43% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.45 days on 15 Jul 2024. Full history: G1 Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024
2024 in figures
- Start of year
- 6.28% (12 Jan 2024)
- End of year
- 8.29% (13 Sep 2024)
- Change
- +2.01 pp
- High
- 13.46% (15 Jul 2024)
- Low
- 4.67% (15 Apr 2024)
- Average
- 7.43%
- Highest days to cover
- 8.45 (15 Jul 2024)
- SEC filings marked
- 7
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 6.28% | 2.46 | results (8-K) |
| 31 Jan 2024 | 5.04% | 1.64 | |
| 15 Feb 2024 | 6.42% | 1.47 | |
| 29 Feb 2024 | 5.62% | 1.70 | 10-K filed, results (8-K) |
| 15 Mar 2024 | 5.20% | 3.61 | |
| 28 Mar 2024 | 5.32% | 2.74 | |
| 15 Apr 2024 | 4.67% | 2.99 | |
| 30 Apr 2024 | 5.41% | 5.19 | |
| 15 May 2024 | 6.86% | 1.00 | 10-Q filed, results (8-K) |
| 31 May 2024 | 7.76% | 4.33 | |
| 14 Jun 2024 | 9.36% | 7.24 | |
| 28 Jun 2024 | 10.89% | 2.41 | |
| 15 Jul 2024 | 13.46% | 8.45 | |
| 31 Jul 2024 | 11.03% | 5.92 | |
| 15 Aug 2024 | 8.32% | 1.00 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 6.46% | 2.17 | |
| 13 Sep 2024 | 8.29% | 2.96 |
See also: G1 Therapeutics, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.